Smallwood Wealth Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Hold
6,574
0.17% 61
2026
Q1
$399K Hold
6,574
0.21% 48
2025
Q4
$355K Hold
6,574
0.19% 57
2025
Q3
$297K Hold
6,574
0.15% 69
2025
Q2
$304K Sell
6,574
-108
-2% -$5.3K 0.17% 62
2025
Q1
$408K Buy
6,682
+2
+0% +$117 0.26% 49
2024
Q4
$378K Hold
6,680
0.26% 54
2024
Q3
$346K Sell
6,680
-704
-10% -$33K 0.25% 55
2024
Q2
$307K Hold
7,384
0.24% 57
2024
Q1
$400K Buy
7,384
+1,000
+16% +$50.9K 0.31% 48
2023
Q4
$328K Sell
6,384
-800
-11% -$42K 0.27% 51
2023
Q3
$417K Hold
7,184
0.38% 40
2023
Q2
$459K Sell
7,184
-172
-2% -$11.5K 0.41% 37
2023
Q1
$510K Sell
7,356
-1,088
-13% -$76.7K 0.48% 34
2022
Q4
$608K Sell
8,444
-395
-4% -$29.8K 0.51% 37
2022
Q3
$628K Buy
8,839
+533
+6% +$38.7K 0.56% 34
2022
Q2
$640K Buy
8,306
+1,143
+16% +$87.1K 0.65% 28
2022
Q1
$523K Buy
+7,163
New +$481K 0.49% 33

Other funds holding BMY

Smallwood Wealth Investment Management's BMY Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,574 shares worth $379K. The position accounts for 0.17% of the portfolio, ranked #61.

Smallwood Wealth Investment Management first reported a position in BMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $640K in Q2 2022. 1,413 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Smallwood Wealth Investment Management held 6,574 shares of Bristol-Myers Squibb worth $379K as of Q2 2026.
  • Smallwood Wealth Investment Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.17% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #61 holding.
  • Smallwood Wealth Investment Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 18 quarters since.
  • Smallwood Wealth Investment Management's Bristol-Myers Squibb position peaked at $640K in Q2 2022.
  • 1,413 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.